{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T19:01:42Z","timestamp":1776452502944,"version":"3.51.2"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.soc.2019.08.006","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T17:06:55Z","timestamp":1574183215000},"page":"73-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Genomics Testing and Personalized Medicine in the\u00a0Preoperative Setting"],"prefix":"10.1016","volume":"29","author":[{"given":"Rodney A.","family":"Gabriel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany N.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Urman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth S.","family":"Waterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.soc.2019.08.006_bib1","first-page":"185","article-title":"Preoperative genetic testing and personalized medicine: changing the care paradigm","volume":"41","author":"Gabriel","year":"2017","journal-title":"J\u00a0Med Syst"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.anclin.2017.01.015","article-title":"Pharmacogenomics in pain management","volume":"35","author":"Saba","year":"2017","journal-title":"Anesthesiol Clin"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.anclin.2017.01.014","article-title":"Pharmacogenomics in anesthesia","volume":"35","author":"Saba","year":"2017","journal-title":"Anesthesiol Clin"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib4","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.anclin.2017.01.018","article-title":"Essential elements of multimodal analgesia in enhanced recovery after surgery (ERAS) guidelines","volume":"35","author":"Beverly","year":"2017","journal-title":"Anesthesiol Clin"},{"issue":"1","key":"10.1016\/j.soc.2019.08.006_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/15360288.2014.997854","article-title":"CYP2D6 phenotype-specific codeine population pharmacokinetics","volume":"29","author":"Linares","year":"2015","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"issue":"1","key":"10.1016\/j.soc.2019.08.006_bib6","first-page":"167","article-title":"Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation","volume":"82","author":"Tateishi","year":"1996","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.soc.2019.08.006_bib7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0090-9556(25)07486-0","article-title":"Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4","volume":"24","author":"Feierman","year":"1996","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.psy.44.2.167","article-title":"Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I","volume":"44","author":"Armstrong","year":"2003","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/clpt.2011.287","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype","volume":"91","author":"Crews","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.soc.2019.08.006_bib10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40262-015-0268-0","article-title":"The pharmacogenetics of tramadol","volume":"54","author":"Lassen","year":"2015","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.soc.2019.08.006_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2125.2003.02002.x","article-title":"CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes","volume":"57","author":"Hutchinson","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.soc.2019.08.006_bib12","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2217\/pgs.14.99","article-title":"ABCC3 and OCT1 genotypes influence\u00a0pharmacokinetics of morphine in children","volume":"15","author":"Venkatasubramanian","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/tpj.2014.56","article-title":"Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics","volume":"15","author":"Sadhasivam","year":"2015","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"10.1016\/j.soc.2019.08.006_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/tpj.2014.59","article-title":"Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents","volume":"15","author":"Chidambaran","year":"2015","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"10.1016\/j.soc.2019.08.006_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1213\/ANE.0000000000000563","article-title":"COMT gene haplotypes are closely associated with postoperative fentanyl dose in patients","volume":"120","author":"Zhang","year":"2015","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.soc.2019.08.006_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00498250310001657559","article-title":"Role of individual human cytochrome P450 enzymes in the in\u00a0vitro metabolism of hydromorphone","volume":"34","author":"Benetton","year":"2004","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.soc.2019.08.006_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/clpt.2010.127","article-title":"OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths","volume":"88","author":"Bunten","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.soc.2019.08.006_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1369-1600.2010.00274.x","article-title":"CYP2B6 and OPRM1 gene variations predict methadone-related deaths","volume":"16","author":"Bunten","year":"2011","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.soc.2019.08.006_bib19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/FPC.0b013e3283385a1c","article-title":"Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)","volume":"21","author":"Hodges","year":"2011","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"10.1016\/j.soc.2019.08.006_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clpt.2004.05.003","article-title":"Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone","volume":"76","author":"Kharasch","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.soc.2019.08.006_bib21","first-page":"515","article-title":"Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review","volume":"9","author":"Carlson","year":"2016","journal-title":"J\u00a0Pain Res"},{"issue":"20","key":"10.1016\/j.soc.2019.08.006_bib22","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","article-title":"Role of CYP2E1 in the hepatotoxicity of acetaminophen","volume":"271","author":"Lee","year":"1996","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib23","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update","volume":"4","author":"Yoon","year":"2016","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000097908","article-title":"Effects of combined UDP-glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on paracetamol pharmacokinetics in beta-thalassemia\/HbE","volume":"79","author":"Tankanitlert","year":"2007","journal-title":"Pharmacology"},{"issue":"9","key":"10.1016\/j.soc.2019.08.006_bib25","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1124\/dmd.111.039149","article-title":"UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables","volume":"39","author":"Navarro","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.soc.2019.08.006_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1124\/jpet.117.242107","article-title":"Race, gender, and genetic polymorphism contribute to variability in acetaminophen pharmacokinetics, metabolism, and protein-adduct concentrations in healthy African-American and European-American volunteers","volume":"362","author":"Court","year":"2017","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.soc.2019.08.006_bib27","first-page":"497","article-title":"Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis","volume":"158","author":"Yamamoto","year":"2015","journal-title":"J\u00a0Biochem"},{"issue":"8","key":"10.1016\/j.soc.2019.08.006_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/FPC.0000000000000150","article-title":"PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses","volume":"25","author":"Mazaleuskaya","year":"2015","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/FPC.0000000000000113","article-title":"PharmGKB summary: ibuprofen pathways","volume":"25","author":"Mazaleuskaya","year":"2015","journal-title":"Pharmacogenet Genomics"},{"issue":"4","key":"10.1016\/j.soc.2019.08.006_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00008571-199608000-00007","article-title":"The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism","volume":"6","author":"Sullivan-Klose","year":"1996","journal-title":"Pharmacogenetics"},{"issue":"4","key":"10.1016\/j.soc.2019.08.006_bib31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2125.2005.02446.x","article-title":"S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen","volume":"60","author":"Bowalgaha","year":"2005","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.soc.2019.08.006_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/17425250902970998","article-title":"Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?","volume":"5","author":"Agundez","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"10.1016\/j.soc.2019.08.006_bib33","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/jcph.169","article-title":"Evaluation of the relationship between polymorphisms in CYP2C8 and CYP2C9 and the pharmacokinetics of celecoxib","volume":"53","author":"Prieto-P\u00e9rez","year":"2013","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.soc.2019.08.006_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2174\/138920009789895480","article-title":"Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance","volume":"10","author":"Wang","year":"2009","journal-title":"Curr Drug Metab"},{"issue":"7","key":"10.1016\/j.soc.2019.08.006_bib35","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1053\/j.gastro.2009.02.045","article-title":"Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma","volume":"136","author":"Chan","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.soc.2019.08.006_bib36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/clpt.2013.128","article-title":"Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance","volume":"94","author":"Shin","year":"2013","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.soc.2019.08.006_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/tpj.2009.21","article-title":"Association of genotypes of the CYP3A cluster with midazolam disposition in\u00a0vivo","volume":"9","author":"Miao","year":"2009","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"10.1016\/j.soc.2019.08.006_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/ACO.0b013e3283556129","article-title":"Pharmacogenetics in perioperative medicine","volume":"25","author":"Cohen","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"issue":"10","key":"10.1016\/j.soc.2019.08.006_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00008571-200310000-00003","article-title":"Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women","volume":"13","author":"Floyd","year":"2003","journal-title":"Pharmacogenetics"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jcph.230","article-title":"CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients","volume":"54","author":"Seng","year":"2014","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/pgs.12.202","article-title":"CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin","volume":"14","author":"Elens","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"11","key":"10.1016\/j.soc.2019.08.006_bib42","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1124\/dmd.110.035295","article-title":"Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7","volume":"38","author":"Seo","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.soc.2019.08.006_bib43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1248\/bpb.23.669","article-title":"Inhibitory effect of azole antifungal agents on the glucuronidation of lorazepam using rabbit liver microsomes in\u00a0vitro","volume":"23","author":"Sawamura","year":"2000","journal-title":"Biol Pharm Bull"},{"issue":"10","key":"10.1016\/j.soc.2019.08.006_bib44","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/j.1552-4604.1994.tb01969.x","article-title":"Disposition of lorazepam in Gilbert's syndrome: effects of fasting, feeding, and enterohepatic circulation","volume":"34","author":"Herman","year":"1994","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.soc.2019.08.006_bib45","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0090-9556(25)06820-5","article-title":"Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans","volume":"23","author":"Dixon","year":"1995","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cpt.598","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron","volume":"102","author":"Bell","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.soc.2019.08.006_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12630-016-0748-1","article-title":"Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review","volume":"64","author":"MacKenzie","year":"2017","journal-title":"Can J Anaesth"},{"issue":"8","key":"10.1016\/j.soc.2019.08.006_bib48","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.clinthera.2014.06.016","article-title":"Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomiting","volume":"36","author":"He","year":"2014","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.soc.2019.08.006_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/tpj.2010.75","article-title":"Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron","volume":"12","author":"Tzvetkov","year":"2012","journal-title":"Pharmacogenomics J"},{"issue":"6","key":"10.1016\/j.soc.2019.08.006_bib50","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MCG.0b013e3182522624","article-title":"Clinical response and side effects of metoclopramide:\u00a0associations with clinical, demographic, and pharmacogenetic parameters","volume":"46","author":"Parkman","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.soc.2019.08.006_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11096-010-9454-1","article-title":"Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics","volume":"33","author":"Perwitasari","year":"2011","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"10.1016\/j.soc.2019.08.006_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S2215-0366(18)30049-X","article-title":"Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study","volume":"5","author":"Yu","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.soc.2019.08.006_bib53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00008571-199610000-00009","article-title":"CYP2D6 is the principal cytochrome P450 responsible for metabolism of the histamine H1 antagonist promethazine in human\u00a0liver microsomes","volume":"6","author":"Nakamura","year":"1996","journal-title":"Pharmacogenetics"},{"issue":"12","key":"10.1016\/j.soc.2019.08.006_bib54","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00228-006-0210-3","article-title":"Impact of CYP2D6*10 on H1-antihistamine-induced hypersomnia","volume":"62","author":"Saruwatari","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.soc.2019.08.006_bib55","first-page":"422","article-title":"Warfarin pharmacogenomics","volume":"34","author":"Li","year":"2009","journal-title":"P\u00a0T"},{"issue":"1","key":"10.1016\/j.soc.2019.08.006_bib56","article-title":"Pharmacogenomic impact of CYP2C19 variation on clopidogrel\u00a0therapy in precision cardiovascular medicine","volume":"8","author":"Brown","year":"2018","journal-title":"J\u00a0Pers Med"},{"issue":"8","key":"10.1016\/j.soc.2019.08.006_bib57","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s11095-017-2104-8","article-title":"CYP2D6 genetic variation and beta-blocker maintenance dose in patients with heart failure","volume":"34","author":"Luzum","year":"2017","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.soc.2019.08.006_bib58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1389200217666151105125425","article-title":"Impact of CYP2D6 genetic variation on the response of the cardiovascular patient to carvedilol and metoprolol","volume":"17","author":"Lymperopoulos","year":"2015","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.soc.2019.08.006_bib59","article-title":"Impact of CYP2D6 and ADRB1 polymorphisms on heart rate of post-PCI patients treated with metoprolol","author":"Gao","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.soc.2019.08.006_bib60","unstructured":"Dean L. Metoprolol therapy and CYP2D6 genotype. In: Pratt V, McLeod H, Dean L, et\u00a0al, editors. Medical genetics summaries. Bethesda (MD): National Center for Biotechnology Information (US); 2012."},{"issue":"3","key":"10.1016\/j.soc.2019.08.006_bib61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000542-200503000-00006","article-title":"Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads","volume":"102","author":"Liem","year":"2005","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.soc.2019.08.006_bib62","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e3182a8a998","article-title":"Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families","volume":"119","author":"Kim","year":"2013","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.soc.2019.08.006_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/JMN:21:1:35","article-title":"Screening for mutations in the RYR1 gene in families with malignant hyperthermia","volume":"21","author":"Muniz","year":"2003","journal-title":"J\u00a0Mol Neurosci"},{"issue":"5","key":"10.1016\/j.soc.2019.08.006_bib64","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/ALN.0b013e3182a8a8e7","article-title":"Using exome data to identify malignant hyperthermia susceptibility mutations","volume":"119","author":"Gonsalves","year":"2013","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib65","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1099800416680474","article-title":"OPRM1 and COMT gene-gene interaction is associated with postoperative pain and opioid consumption after orthopedic trauma","volume":"19","author":"Khalil","year":"2017","journal-title":"Biol Res Nurs"},{"issue":"5","key":"10.1016\/j.soc.2019.08.006_bib66","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5414\/CP201824","article-title":"Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4\/5 on postoperative fentanyl consumption in Korean gynecologic patients","volume":"51","author":"Kim","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib67","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1213\/ANE.0b013e318273f2c7","article-title":"The effect of OPRM1 and COMT genotypes on the analgesic response to intravenous fentanyl labor analgesia","volume":"116","author":"Landau","year":"2013","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.soc.2019.08.006_bib68","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.amjsurg.2016.11.008","article-title":"Pharmacogenetics-guided analgesics in major abdominal surgery: further benefits within an enhanced recovery protocol","volume":"213","author":"Senagore","year":"2017","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.soc.2019.08.006_bib69","first-page":"628","article-title":"Human genetic variability contributes to postoperative morphine consumption","volume":"17","author":"De Gregori","year":"2016","journal-title":"J\u00a0Pain"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib70","first-page":"131","article-title":"The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis","volume":"18","author":"Ren","year":"2015","journal-title":"Pain Physician"},{"issue":"3","key":"10.1016\/j.soc.2019.08.006_bib71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1099800411436171","article-title":"The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation","volume":"15","author":"Henker","year":"2013","journal-title":"Biol Res Nurs"},{"issue":"3","key":"10.1016\/j.soc.2019.08.006_bib72","first-page":"E227","article-title":"The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone","volume":"16","author":"Boswell","year":"2013","journal-title":"Pain Physician"},{"issue":"9","key":"10.1016\/j.soc.2019.08.006_bib73","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/AJP.0b013e3182442b1c","article-title":"Natural variation in the mu-opioid gene OPRM1 predicts increased pain on third day after thoracotomy","volume":"28","author":"Ochroch","year":"2012","journal-title":"Clin J Pain"},{"issue":"9","key":"10.1016\/j.soc.2019.08.006_bib74","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00228-013-1523-7","article-title":"Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain","volume":"69","author":"De Gregori","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 4","key":"10.1016\/j.soc.2019.08.006_bib75","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.33549\/physiolres.933210","article-title":"OPRM1 and ABCB1 polymorphisms and their effect on postoperative pain relief with piritramide","volume":"64","author":"Bartosova","year":"2015","journal-title":"Physiol Res"},{"issue":"11","key":"10.1016\/j.soc.2019.08.006_bib76","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2217\/14622416.9.11.1605","article-title":"Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype","volume":"9","author":"Hayashida","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.soc.2019.08.006_bib77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/0091270010397729","article-title":"Lack of association of OPRM1 and ABCB1 single-nucleotide polymorphisms to oxycodone response in postoperative pain","volume":"52","author":"Zwisler","year":"2012","journal-title":"J\u00a0Clin Pharmacol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105532071930078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105532071930078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:03:58Z","timestamp":1760961838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105532071930078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S105532071930078X"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2019.08.006","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomics Testing and Personalized Medicine in the\u00a0Preoperative Setting","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2019.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}